Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Pharmaceutical Technology29m
Google-backed Isomorphic Labs raises $600m to advance AI drug discovery
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
Google DeepMind’s drug discovery spin-off Isomorphic Labs raises $600mn
Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...
Alphabet-backed Isomorphic Labs bags $600 million funding to build next-gen AI drug design engine
Isomorphic Labs is raising money in its first-ever external funding round from Thrive Capital, a big backer of ChatGPT ...
Google-backed AI drug discovery startup raises $600 million
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.
Fierce Biotech2h
Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Google plans to release new ‘open’ AI models for drug discovery
During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models ...
Google unveils a next-gen family of AI reasoning models
Google has unveiled Gemini 2.5, the company's new family of AI reasoning models that will pause to 'think' before answering.
Citizen Digital9h
Gemini 2.5: Google introduces its ‘most intelligent AI model’ yet
Google has begun rolling out Gemini 2.5, which the tech giant touts as the “most intelligent AI model” its research lab ...